ENTRADA THERAPEUTICS
Entrada Therapeutics’ mission is to treat devastating diseases through the intracellular delivery of biologics. Entrada’s technology enables the efficient intracellular delivery of proteins, peptides and nucleic acids, thus allowing for the development of programs across several intracellular target classes. The Company's novel approach addresses current challenges associated with both large and small molecule therapeutics and represents a fundamental advancement in the delivery of molecules into the cytosol. For more information, please visit www.entradatx.com.
ENTRADA THERAPEUTICS
Social Links:
Industry:
Biotechnology Emergency Medicine Genetics Health Care Medical
Founded:
2016-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.entradatx.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
175.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Global Site Tag
Similar Organizations
AmbAgon Therapeutics
AmbAgon Therapeutics is a developer of cancer molecule therapeutics.
Cognos Therapeutics
Cognos Therapeutics is a developer of diagnostic and drug delivery devices to detect diseases and deliver drugs.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Emedgene
Emedgene provides data-driven AI solutions for genomic diagnostics and discovery at scale.
EnteroBiotix
EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections.
Erasca
Erasca is a developer of oncology drugs intended to provide precision oncology options.
MiNDERA Corporation
MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases.
Neuron23
Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
Pyxis Oncology
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.
Spatial Genomics
Spatial Genomics is a developer of sequential fluorescence in situ hybridization (seqFISH) technology.
Vedanta Biosciences
Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases.
Vico Therapeutics
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Wellington Management
Wellington Management investment in Series B - Entrada Therapeutics
TCG Crossover
TCG Crossover investment in Series B - Entrada Therapeutics
MRL Ventures Fund
MRL Ventures Fund investment in Series B - Entrada Therapeutics
MPM Capital
MPM Capital investment in Series B - Entrada Therapeutics
Greenspring Associates
Greenspring Associates investment in Series B - Entrada Therapeutics
CureDuchenne Ventures
CureDuchenne Ventures investment in Series B - Entrada Therapeutics
Redmile Group
Redmile Group investment in Series B - Entrada Therapeutics
Moore Strategic Ventures
Moore Strategic Ventures investment in Series B - Entrada Therapeutics
5AM Ventures
5AM Ventures investment in Series B - Entrada Therapeutics
Agent Capital
Agent Capital investment in Series B - Entrada Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-19 | Entrada Therapeutics Appoints Karla MacDonald as Chief Corporate Affairs Officer |
Official Site Inspections
http://www.entradatx.com Semrush global rank: 2.84 M Semrush visits lastest month: 5.7 K
- Host name: 165.227.248.71
- IP address: 165.227.248.71
- Location: Clifton United States
- Latitude: 40.8364
- Longitude: -74.1403
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07014
